Cargando…
Formulation and Optimization of Clotrimazole-Loaded Proniosomal Gel Using 3(2) Factorial Design
The main aim of the study was to develop and statistically optimize the proniosomal gel for enhanced transdermal delivery using 3(2) factorial designs to investigate the influence of both non-ionic surfactant and cholesterol to maximize the entrapment efficiency and flux. The concentration of non-io...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Österreichische Apotheker-Verlagsgesellschaft
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447614/ https://www.ncbi.nlm.nih.gov/pubmed/23008818 http://dx.doi.org/10.3797/scipharm.1201-03 |
_version_ | 1782244126021910528 |
---|---|
author | Thomas, Litha Viswanad, Vidya |
author_facet | Thomas, Litha Viswanad, Vidya |
author_sort | Thomas, Litha |
collection | PubMed |
description | The main aim of the study was to develop and statistically optimize the proniosomal gel for enhanced transdermal delivery using 3(2) factorial designs to investigate the influence of both non-ionic surfactant and cholesterol to maximize the entrapment efficiency and flux. The concentration of non-ionic surfactant and cholesterol were taken as independent variables, while entrapment efficiency and flux were taken as dependent variables. The study showed that the entrapment efficiency depends on both cholesterol and surfactant, whereas permeation flux depends only on the surfactant. Proniosomal gel showed a significantly enhanced drug permeation through the skin, with an enhancement ratio 3.81±1.85 when compared to the drug solution. Comparative evaluation of permeation studies and the in vitro release study of optimized proniosomal gel (F5) with that of marketed gel and carbopol gel showed that the penetration of the optimized formulation was enhanced 1.75 times in comparison with that of the marketed formulation, and the release was in a controlled manner. Similarly, the anticandidial activity showed a significantly higher activity (p<0.05) than the marketed and carbopol gel. This may be due to the enhanced penetration of noisome-containing drug through the fungal cell wall, inhibiting the ergo sterol synthesis, thereby causing the fungal cell death due to the presence of penetration enhancer. The stability study at two different temperatures (30 ± 2°C and 4 ± 2°C) confirmed that the formulations were stable even at the end of 45 days. Hence, proniosomal gel is an efficient carrier for the delivery of clotrimazole, thereby prolonging the action. |
format | Online Article Text |
id | pubmed-3447614 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Österreichische Apotheker-Verlagsgesellschaft |
record_format | MEDLINE/PubMed |
spelling | pubmed-34476142012-09-24 Formulation and Optimization of Clotrimazole-Loaded Proniosomal Gel Using 3(2) Factorial Design Thomas, Litha Viswanad, Vidya Sci Pharm Research Article The main aim of the study was to develop and statistically optimize the proniosomal gel for enhanced transdermal delivery using 3(2) factorial designs to investigate the influence of both non-ionic surfactant and cholesterol to maximize the entrapment efficiency and flux. The concentration of non-ionic surfactant and cholesterol were taken as independent variables, while entrapment efficiency and flux were taken as dependent variables. The study showed that the entrapment efficiency depends on both cholesterol and surfactant, whereas permeation flux depends only on the surfactant. Proniosomal gel showed a significantly enhanced drug permeation through the skin, with an enhancement ratio 3.81±1.85 when compared to the drug solution. Comparative evaluation of permeation studies and the in vitro release study of optimized proniosomal gel (F5) with that of marketed gel and carbopol gel showed that the penetration of the optimized formulation was enhanced 1.75 times in comparison with that of the marketed formulation, and the release was in a controlled manner. Similarly, the anticandidial activity showed a significantly higher activity (p<0.05) than the marketed and carbopol gel. This may be due to the enhanced penetration of noisome-containing drug through the fungal cell wall, inhibiting the ergo sterol synthesis, thereby causing the fungal cell death due to the presence of penetration enhancer. The stability study at two different temperatures (30 ± 2°C and 4 ± 2°C) confirmed that the formulations were stable even at the end of 45 days. Hence, proniosomal gel is an efficient carrier for the delivery of clotrimazole, thereby prolonging the action. Österreichische Apotheker-Verlagsgesellschaft 2012 2012-05-03 /pmc/articles/PMC3447614/ /pubmed/23008818 http://dx.doi.org/10.3797/scipharm.1201-03 Text en © Thomas and Viswanad; licensee Österreichische Apotheker-Verlagsgesellschaft m. b. H., Vienna, Austria. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Thomas, Litha Viswanad, Vidya Formulation and Optimization of Clotrimazole-Loaded Proniosomal Gel Using 3(2) Factorial Design |
title | Formulation and Optimization of Clotrimazole-Loaded Proniosomal Gel Using 3(2) Factorial Design |
title_full | Formulation and Optimization of Clotrimazole-Loaded Proniosomal Gel Using 3(2) Factorial Design |
title_fullStr | Formulation and Optimization of Clotrimazole-Loaded Proniosomal Gel Using 3(2) Factorial Design |
title_full_unstemmed | Formulation and Optimization of Clotrimazole-Loaded Proniosomal Gel Using 3(2) Factorial Design |
title_short | Formulation and Optimization of Clotrimazole-Loaded Proniosomal Gel Using 3(2) Factorial Design |
title_sort | formulation and optimization of clotrimazole-loaded proniosomal gel using 3(2) factorial design |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447614/ https://www.ncbi.nlm.nih.gov/pubmed/23008818 http://dx.doi.org/10.3797/scipharm.1201-03 |
work_keys_str_mv | AT thomaslitha formulationandoptimizationofclotrimazoleloadedproniosomalgelusing32factorialdesign AT viswanadvidya formulationandoptimizationofclotrimazoleloadedproniosomalgelusing32factorialdesign |